-
CryoLife; Medafor; diaDexus; Fisher HealthCare; Micrus Endovascular; Chemence Medical Products; Naval Medical Research Center; St. Jude Medical; Microsoft Health Solutions Group
-
Boston Scientific; CryoCor; Surgi-Vision; Bovie Medical; Opto Circuits; Criticare Systems; Pediatrix Medical Group
-
Long considered a problem only for high-income countries, now 80% of deaths connected to high blood pressure (BP) occur in the developing world, according to an article in a recent edition of The Lancet. The report says that cardiovascular disease is now endemic, worldwide, and no longer limited only to developed countries.
-
Robotic-assisted, minimally invasive cardiac procedures avoid the drawbacks of traditional heart surgery, such as the blood loss, pain and scarring that typically results from cutting through the breastbone or opening the ribs.
-
SILVER SPRING, Maryland The cost of developing a drug-eluting stent (DES) has been pegged as somewhere north of $100 million, but that number has not deterred several device makers from wading into this end of the cardiovascular device pool.
-
In light of recent news that blood substitutes have led to a 30% increase in the risk of death and a nearly threefold chance of having a heart attack, Synthetic Blood International (SBI; Costa Mesa, California) has attempted to distance itself from the "blood substitute" sector.
-
A treatment protocol and a communitywide task force are among the initiatives Harris Methodist Southwest Hospital in Fort Worth, TX, has initiated to help adults with sickle cell disease learn to manage their condition and limit their visits to the hospital.
-
When MCGHealth was planning a new neuroscience unit at its Augusta, GA, facility, patients and family members were involved every step of the way.
-
Including patients and family members in everything from developing a plan of care to making changes in the hospital's physical appearance has paid off at MCGHealth in Augusta, GA.
-
